Alexander B. Olawaiye
Dr. Alexander B. Olawaiye is the director of gynecological cancer research at Magee-Women’s Hospital at the University of Pittsburgh. He is a principal investigator in the ROSELLA trial, which explores the efficacy of the new drug Relacorilant in treating treatment-resistant ovarian cancer, showing promising results in improving overall survival rates.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Alexander B. Olawaiye, MD, director of gynecological cancer research at Magee-Women’s Hospital at the University of Pittsburgh and principal investigator in the ROSELLA trial, discussed the results with Fox News Digital.
8